Cellular determinants of oxaliplatin sensitivity in colon cancer cell lines

Author： Arnould S.   Hennebelle I.   Canal P.   Bugat R.   Guichard S.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.39, Iss.1, 2003-01, pp. : 112-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nitrogen permease regulatorlike 2 enhances sensitivity to oxaliplatin in colon cancer cells

By                

Molecular Medicine Reports, Vol. 12, Iss. 1, 2015-01 ,pp. : 1189-1196

Spandidos Publications

Access to resources Recommend Favorite

In vitro radiosensitization by oxaliplatin and 5-fluorouracil in a human colon cancer cell line

By Kjellström Johan   Kjellén Elisabeth   Johnsson Anders  

Acta Oncologica, Vol. 44, Iss. 7, 2005-10 ,pp. : 687-693

Informa Healthcare

Access to resources Recommend Favorite

ErbB3 expression predicts sensitivity to elisidepsin treatment: in vitro synergism with cisplatin, paclitaxel and gemcitabine in lung, breast and colon cancer cell lines

By                  

International Journal of Oncology, Vol. 41, Iss. 1, 2012-01 ,pp. : 317-324

Spandidos Publications

Access to resources Recommend Favorite

Rapamycin synergizes with low dose oxaliplatin in the HCT116 colon cancer cell line by inducing enhanced apoptosis

By            

Oncology Letters, Vol. 2, Iss. 4, 2011-01 ,pp. : 643-647

Spandidos Publications

Access to resources Recommend Favorite

Enhancement of oxaliplatin-induced cell apoptosis and tumor suppression by 3-methyladenine in colon cancer

By          

Oncology Letters, Vol. 9, Iss. 5, 2015-01 ,pp. : 2056-2062

Spandidos Publications

Access to resources Recommend Favorite